ZNF558 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.76730002538528E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.31740000003578E-06 |
Normal-vs-Stage2 |
3.659600E-02 |
Normal-vs-Stage3 |
5.332000E-01 |
Normal-vs-Stage4 |
5.073800E-01 |
Stage1-vs-Stage2 |
8.536800E-01 |
Stage1-vs-Stage3 |
6.275900E-02 |
Stage1-vs-Stage4 |
3.087800E-01 |
Stage2-vs-Stage3 |
1.245400E-01 |
Stage2-vs-Stage4 |
3.215000E-01 |
Stage3-vs-Stage4 |
8.443200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.18989999467567E-08 |
Normal-vs-AfricanAmerican |
4.719600E-03 |
Normal-vs-Asian |
3.904000E-01 |
Caucasian-vs-AfricanAmerican |
2.354400E-01 |
Caucasian-vs-Asian |
8.245800E-01 |
AfricanAmerican-vs-Asian |
8.361400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.80989999987169E-07 |
Normal-vs-Female |
2.12099999999937E-05 |
Male-vs-Female |
6.638000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.856100E-03 |
Normal-vs-Extreme_Weight |
2.339000E-03 |
Normal-vs-Obese |
4.150100E-04 |
Normal-vs-Extreme_Obese |
3.715200E-01 |
Normal_Weight-vs-Extreme_Weight |
4.279800E-01 |
Normal_Weight-vs-Obese |
9.993000E-01 |
Normal_Weight-vs-Extreme_Obese |
4.461400E-01 |
Extreme_Weight-vs-Obese |
3.766600E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.003200E-01 |
Obese-vs-Extreme_Obese |
4.269800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.009800E-02 |
Normal-vs-Age(41-60Yrs) |
3.47509999665263E-08 |
Normal-vs-Age(61-80Yrs) |
5.78540000000238E-05 |
Normal-vs-Age(81-100Yrs) |
9.053600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.923600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.361600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.577900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.969620E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.600400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.226220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
8.91642315536956E-12 |
Normal-VS-Type2 PRCC |
4.371200E-01 |
Normal-VS-KIRP CIMP |
5.028600E-01 |
Normal-VS-Unclassified PRCC |
2.539400E-03 |
Type1 PRCC-VS-Type2 PRCC |
1.51340051601778E-11 |
Type1 PRCC-VS-KIRP CIMP |
9.870300E-02 |
Type1 PRCC-VS-Unclassified PRCC |
2.388600E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.803800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
2.372800E-04 |
KIRP CIMP-VS-Unclassified PRCC |
2.693400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.594200E-02 |
Normal-vs-N1 |
1.266250E-01 |
Normal-vs-N2 |
2.379600E-02 |
N0-vs-N1 |
8.605800E-01 |
N0-vs-N2 |
1.028750E-01 |
N1-vs-N2 |
1.035820E-01 |
|
|